Pfizer says South African COVID-19 variant could reduce protection by TWO-THIRDS
A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday. The study found the vaccine was still able to neutralize the virus … Read more